Drug application
VASOCON-A (ANTAZOLINE PHOSPHATE, NAPHAZOLINE HYDROCHLORIDE)
Drugs@FDA NDA 018746 · NOVARTIS
Key facts
| Drug name | VASOCON-A |
|---|---|
| Active ingredients | ANTAZOLINE PHOSPHATE, NAPHAZOLINE HYDROCHLORIDE |
| Application type | NDA |
| Application number | 018746 |
| Company | NOVARTIS |
| Dosage forms | SOLUTION/DROPS, OPHTHALMIC |
| Strength | 0.5%;0.05% |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 6 - New Indication (no longer used) |
| Latest submission status date | Apr 30, 1990 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.